ArticleAsian journal of urology2026
High prevalence of low testosterone in men undergoing urologic surgery: Results of a prospective study.
Article in Asian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the prevalence of low serum testosterone in men undergoing urologic surgery and the associations between low testosterone, frailty, and postoperative outcomes. Methods: A prospective study of adult men undergoing urologic surgery between October 2022 and October 2024 was conducted. Morning serum testosterone levels were measured, and baseline sociodemographic characteristics and comorbid medical conditions were collected. The clinical Risk Analysis Index for measuring frailty in surgical populations was calculated. Postoperative outcomes were assessed up to 90 days after surgery. Results: We enrolled 125 patients with a mean age of 64.4 years and a median body mass index of 28.1 (interquartile range 25.6-31.8) kg/m Conclusion: Our study of patients undergoing urologic surgery found a high prevalence of low testosterone (45%). Urologists should consider evaluating all surgical patients for symptomatic hypogonadism. Further research on the postoperative implications of low testosterone and on the role of testosterone replacement therapy in the perioperative setting is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.